Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Accumulated Depreciation (2018 - 2019)

Historic Accumulated Depreciation for Autolus Therapeutics (AUTL) over the last 2 years, with Q1 2019 value amounting to -$4.8 million.

  • Autolus Therapeutics' Accumulated Depreciation changed N/A to -$4.8 million in Q1 2019 from the same period last year, while for Mar 2019 it was -$4.8 million, marking a year-over-year change of. This contributed to the annual value of -$3.7 million for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q1 2019, Autolus Therapeutics' Accumulated Depreciation is -$4.8 million.
  • Autolus Therapeutics' 5-year Accumulated Depreciation high stood at -$3.7 million for Q4 2018, and its period low was -$4.8 million during Q1 2019.